コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ers (cis/syn, cis/anti, trans/syn, and trans/anti).
2 the NHC backbone (vs the initially expected anti).
3 ucleobase into two different domains (syn or anti).
4 reactive halogenated radicals (6f,g) (>15:1 anti).
5 hoxy group is oriented toward the other (syn-anti).
6 "Pro") or away from it, toward its reverse ("Anti").
7 naute-like gene) that are antimorphic [alg-1(anti)].
8 on correlated with ribosome affinity for the anti (1,4)-regioisomers as revealed by measured Kd value
9 nocyclohexane can be differentiated using Sc[anti-(-)-1](2) in the same ligand displacement assay.
10 of compound 6 can be fixed predominantly to anti (17a and 17b) by introducing bulky alkyl groups (e.
17 e that an approximately 370-MBq injection of anti-(18)F-FACBC yields good imaging and acceptable dosi
18 3-(18)F-fluorocyclobutane-1-carboxylic acid (anti-(18)F-FACBC) is a recently developed ligand that pe
19 3-(18)F-fluorocyclobutane-1-carboxylic acid (anti-(18)F-FACBC)is a synthetic l-leucine analog that ha
22 a right-handed helix with all nucleotides in anti, 2'-deoxyribose conformations within the C2'-endo/C
23 P (4b) with epi-isozizaene synthase gave [11(anti)-(2)H]epi-isozizaene (3b), indicating that the S(N)
24 levels of spontaneously appearing monoclonal anti-(2-->8)-alpha-Neu5Ac did not cause autoimmunity.
28 Synthesis of a variety of 8,16-disubstituted-anti-[2.2]metacyclophanedienes (CPD) with alkenyl and al
29 mbinant DH4 with chemoenzymatically prepared anti-(2R,3R)-2-methyl-3-hydroxypentanoyl-ACP (2a-ACP) ga
30 EBS [KS6][AT6], DEBS ACP6, and TYLS KR1 gave anti-(2R,3R)-6-ACP that underwent syn dehydration cataly
31 y syn-dehydration of the ACP-bound substrate anti-(2R,3R,4S,5R)-2,4-dimethyl-3,5-dihydroxyheptanoyl-A
32 e syn-(2S,3R)-2b-ACP, syn-(2R,3S)-2c-ACP, or anti-(2S,3S)-2d-ACP generated in situ by DEBS KR1, DEBS
33 4, with a 20-fold greater kcat/K(m) than the anti-(2S,3S)-diketide-SNAC 14, and a 40-fold advantage o
34 ree isomeric forms with hydrides in syn (2), anti (3), and cis (4) conformations have been characteri
35 te a curative CTL response, is necessary for anti--4-1BB mAb to induce a CTL response leading to the
36 (OHMT)Cl in solution as a mixture of syn and anti (60:40 at 0.015 M) nitrile-free isomers, but these
38 formed on Sprague-Dawley rats using syn- and anti-(99m)Tc-L- and -D-MAEC coinjected with (131)I-OIH.
40 a clearance ratio in humans ranged from 45% (anti-(99m)Tc-L-MAEC) to 74% (syn-(99m)Tc-D-MAEC) with th
42 t a predominant conformation: a sheared anti-anti (A.A trans Hoogsteen/Sugar-edge) alignment similar
43 (rGGCAAGCCU)(2) duplex has sheared A(anti).A(anti) (A.A trans Hoogsteen/Sugar-edge) pairs in which th
44 The 5'(rGGCAAGCCU)(2) duplex has sheared A(anti).A(anti) (A.A trans Hoogsteen/Sugar-edge) pairs in
45 he N(CH2)3N units on each side are in doubly anti (aa) conformations that put the aryl rings as far a
46 ogen-containing coronene-type molecules like anti-(ab)2-PBI 15, syn-(ab)2-PBI 16, and syn-(ab)2-PTE 1
47 tion having one PD(+) ring syn and the other anti (abbreviated uns) was seen, and the relative amount
49 odies (mAb), designed to stimulate immunity [anti-(alpha)-CD137, alpha-CD40] or relieve immunosuppres
53 in various orientations [C*C, A*G, and G*G (anti) and A*G and G*G (syn)] and compare the results to
54 or the purine base, as expected for A(syn)*T(anti) and G(syn)*C(+)(anti) HG base pairing, HG type hyd
56 s performed with beta-hydroxy aldehydes 37a (anti) and the corresponding p-methoxybenzyl (PMB) ether
57 having the same G-arrangement (anti:anti:syn:anti) and the top G-tetrad having the reversed G-arrange
58 symmetric (er > 99:1) total synthesis of (+)-anti- and (-)-syn-mefloquine hydrochloride from a common
59 ymmetric (>99:1 e.r.) total synthesis of (+)-anti- and (-)-syn-mefloquine hydrochloride from a common
60 stallographic analysis of derivatives of (+)-anti- and (-)-syn-mefloquine is used to lay to rest a 40
64 crotyl reagents afford the corresponding 1,3-anti- and 1,3-syn-methyl-substituted "homocrotylated" al
67 ngaging in protein-protein interactions with anti- and pro-apoptotic Bcl2 family members, thereby exe
68 dihydrodiol and BPDE-2 treatment, changes in anti- and pro-apoptotic events in the Bcl-2 family of pr
71 , thus indicating the involvement of various anti- and pro-apoptotic regulators in the signaling casc
73 ein transduction to identify novel, opposing anti- and pro-cytokine-inducing roles for RhoA in the re
74 t directly affect the expression of Foxp3 or anti- and pro-inflammatory cytokines in T(reg) cells, su
75 or necrosis factor-alpha (TNF-alpha) are key anti- and pro-inflammatory mediators elicited during the
77 aging to date and the first to discriminate anti- and pro-longevity genes, revealing new insights on
78 Tiam1 and P-Rex1, two Rac GEFs, promote Rac1 anti- and pro-migratory signalling cascades, respectivel
79 l is proposed for quantifying simultaneously anti- and pro-oxidant activities as function of concentr
80 -induced dysregulations of the expression of anti- and pro-oxidant enzymes, mitochondrial biogenesis
83 phages have been shown previously to be both anti- and proangiogenic, and their role in regulating an
89 DL(Healthy) on the activation of endothelial anti- and proapoptotic pathways and to determine which c
92 the first to show that Hax-1 is a family of anti- and proapoptotic regulators that may modulate cell
93 s a pleiotropic cytokine that activates both anti- and proapoptotic signaling pathways, with cell fat
94 lead to the simultaneous activation of both anti- and proapoptotic signaling pathways; the balance u
95 CP in modulating the responses between these anti- and profibrotic cytokines in the initiation and pr
96 pe I IFNs regulate the balance between IL-10 anti- and proinflammatory activity, and provide insight
98 appaB (nuclear factor kappaB), expression of anti- and proinflammatory factors and of the MAP (mitoge
99 was undertaken in order to exploit both the anti- and proinflammatory properties attributed to the v
100 ferentiation remains elusive given that both anti- and promyogenic activities have been described.
103 determine how pol beta discriminates between anti- and syn-8-oxoG, we introduced a point mutation (R2
104 as been developed to make the optically pure anti- and syn-beta-substituted cysteine and serine deriv
106 roup increases the energy difference between anti- and syn-chairs with primary amino acid catalysts a
107 n has dual coding potential by virtue of its anti- and syn-conformations, base pairing with cytosine
108 (BTBPE), and hexabromocyclododecane (HBCDD), anti- and syn-Dechlorane plus were detected at levels co
109 ion results in stereodivergent products with anti- and syn-diastereomers both in good diastereoselect
111 the assignment of the stereochemistry of the anti- and syn-diepoxy and -tetraepoxy derivatives as wel
112 rcinogenic metabolite, and the corresponding anti- and syn-diol epoxides of BcF (3 and 4) in which th
120 diastereoselective syntheses of a variety of anti, anti-stereotriads, the direct synthesis of which h
121 and to determine the lower cut-off value of anti- anti-TTG level that best predicts CD in children w
124 8), microRNA guide strand selection by ALG-1(anti) appeared normal, but microRNA* strand release was
125 some microRNA* strands present in the ALG-1(anti) Argonaute far in excess of the corresponding matur
129 m the dual coding potential where 8-oxo-dGTP(anti) base pairs with cytosine and 8-oxo-dGTP(syn) uses
130 simple model accurately predicts the bonding/anti- bonding modes that are measured experimentally.
131 he two distinct CH3CHOO conformers, syn- and anti-, both of which react readily with SO2 and with NO2
132 ailable for these 10S (+)- and 10R (-)-trans-anti -[BP]-N(2)-dG adducts in double-stranded deoxyoligo
133 ene-derived N (2)-dG adduct, 10 S(+)- trans- anti-[BP]- N (2)-dG ([BP]G*), reveal that an incoming dA
135 via trans epoxide opening to form (+)-trans-anti-[BP]-N(2)-dG ((+)-ta[BP]G) and (-)-trans-anti-[BP]-
137 pyrene-derived N(2)-dG adduct, 10S-(+)-trans-anti-[BP]-N(2)-dG ([BP]G*), is processed in Dpo4, the we
138 vironmental carcinogen, is the 10S (+)-trans-anti-[BP]-N(2)-dG adduct (G*), which resides in the B-DN
139 The modeling required that the (+)-trans-anti-[BP]-N(2)-dG adduct adopt the syn conformation in e
140 leotides are inserted opposite the (+)-trans-anti-[BP]-N(2)-dG adduct by bacteriophage T7 DNA polymer
143 mental observations concerning the (+)-trans-anti-[BP]-N(2)-dG adduct in double-stranded DNA with the
145 Dpo4 is able to bypass the 10S (+)-trans-anti-[BP]-N(2)-dG adduct, albeit to a lesser extent than
146 attacks DNA to form the major 10S (+)-trans-anti-[BP]-N(2)-dG adduct, which has been shown to be mut
149 incorporation preference opposite (+)-trans-anti-[BP]-N(2)-dG by T7 DNA polymerase contributes to pr
150 utational studies suggest that 10S (+)-trans-anti-[BP]-N(2)-dG can be accommodated in the active site
151 carcinogen-DNA adducts, including (+)-trans-anti-[BP]-N(2)-dG derived from the reaction of (+)-anti-
152 ulations of dTTP and dGTP opposite (+)-trans-anti-[BP]-N(2)-dG exhibited more instability in interact
153 zation of each nucleotide opposite (+)-trans-anti-[BP]-N(2)-dG in the +1 position (T > G > A > or = C
154 eferential insertion of A opposite (+)-trans-anti-[BP]-N(2)-dG is independent of the sequence context
156 cidated why A is inserted opposite (+)-trans-anti-[BP]-N(2)-dG most frequently, while T and G are ins
159 hydrogen bond between dCTP and the (+)-trans-anti-[BP]-N(2)-dG residue evolved during the simulation,
161 udies of nucleotide incorporation, (+)-trans-anti-[BP]-N(2)-dG was modeled in the syn conformation in
162 ss of the base positioned opposite (+)-trans-anti-[BP]-N(2)-dG, extension of the primer past the lesi
164 er-extension of each base opposite (+)-trans-anti-[BP]-N(2)-dG, we carried out molecular modeling and
165 n intermediate preference opposite (+)-trans-anti-[BP]-N(2)-dG, were accommodated reasonably well, bu
166 ernary complex containing this 10S (+)-trans-anti-[BP]-N(6)-dA adduct in the templating position with
167 formations of the 10S (+)- and 10R (-)-trans-anti-[BP]-N(6)-dA adducts through molecular dynamics (MD
168 dies have been carried out for 10S-(+)-trans-anti-[BP]-N2-dG ((+)-ta-[BP]G), a lesion derived from th
169 [a]pyrene-derived N2-dG adduct, 10S(+)-trans-anti-[BP]-N2-dG ([BP]G*), is processed in a well-charact
170 bserved for the stereoisomeric 10S (+)-trans-anti-[BP]G adduct in both the C-[BP]G and meC-[BP]G sequ
171 d NMR study indicates that the 10R (-)-trans-anti-[BP]G adduct undergoes a transition from a minor gr
174 These observations have demonstrated that an anti- but not proapoptotic activity is the prevailing ev
175 dry mouth but F = 0, increased expression of anti- CA6 was noted compared to the F <1 group (p = .032
178 he total (CD68(+)), pro- (CD14(+) = M1), and anti- (CD206(+) = M2) inflammatory macrophages, crown-li
180 enger) strands, and immunoprecipitated ALG-1(anti) complexes contained nonstoichiometric yields of ma
182 uorophenyl) TEFDDOL, a quite unusual "pseudo-anti" conformation of the diol, with no intramolecular (
185 ar-reaching analogies are established among (anti-) cooperative collective behaviors in chemical kine
186 ly associated with RA (P<10(-4)): *0301 with anti- cyclic citrullinated peptide-negative RA and *0701
190 IgA anti-tissue transglutaminase and/or IgA anti- endomysium permitted diagnosis or exclusion of CD
191 collective behaviors in chemical kinetics, (anti-)ferromagnetic spin models in statistical mechanics
192 Phase boundaries in multiferroics, in which (anti-)ferromagnetic, ferroelectric and ferroelastic orde
193 one- and two-dimensional spin systems with (anti)-ferromagnetic interactions controlled by their sym
194 uctural studies demonstrate that 8-OG(syn):G(anti) forms a stable pair in the interior of the duplex,
195 s the cap in multiple conformations (syn and anti) giving rise to a relatively plastic and nonspecifi
196 modulation was done by treatments with DTA-1 anti- glucocorticoid-induced tumor necrosis factor recep
197 he (NIASF), no increase in the prevalence of anti- gp130-RAPS antibodies was observed in serum or syn
200 expected for A(syn)*T(anti) and G(syn)*C(+)(anti) HG base pairing, HG type hydrogen bonding could on
208 evels for pro (IFN-gamma and TNF-alpha)- and anti (IL-4 and IL-10)-inflammatory cytokines also were d
213 a postinsertional complex shows 8oG(syn).dA (anti) in a Hoogsteen-like base pair at the 3' terminus,
214 atio of the two limiting conformers (syn and anti) in solution and the extent of conjugation between
216 nsition states, endo-prox-anti and endo-dist-anti, in the pentadiene/PyrNO reaction, leading to nearl
217 RNA* strands were selected as guide by ALG-1(anti), indicating a defect in normal specificity of the
218 ponses by differentially regulating pro- and anti- inflammatory cytokine production in innate immune
219 modulate the expression of selected pro- and anti- inflammatory mediators such as IL-6 and IL-33.
220 ave been reported to modulate either pro- or anti- inflammatory programs, which may be specific to th
221 stances is linked mainly to the antioxidant, anti- inflammatory, anti-proliferative and cardioprotect
229 to three contiguous stereocentres in a (syn, anti)-mode with excellent regio and diastereoselectiviti
231 Sjorgen's Syndrome (SS) and HCV, presence of anti- muscarinic receptor type 3 (M3R) antibodies in SS,
234 (syn, Pseudomonas fluorescens, gi 70731221 ; anti, Mycobacterium smegmatis, gi 118470554 ) document t
236 )+(R)] and the elimination mechanism (syn or anti), not substituent effects, determined the configura
238 he N-heterocyclic carbene ligand IMes to fac,anti-(ONO(Cat))Re(O)(mu-O)2Re(O)(ONO(Cat)) cleaves the d
240 ular flux analysis of cells transfected with anti- or pre- miR-29a confirmed that miR-29a inhibits mi
245 as a bifunctional regulator promoting either anti- or profibrogenic response, depending on milieu.
247 ies in both mice and humans suggest that the anti- or proinflammatory nature of high density lipoprot
249 nin is a convergent site for the activity of anti- or propsychotic drugs, opening a possibility for n
250 possessing di- or trisubstituted alkenes and anti- or syn- relative stereochemistry at the allylic an
252 with aromatic aldehydes and preparing either anti- or syn-aldol adducts with very high enantioselecti
254 n them, hydrogen bonds relating parallel and anti- parallel beta strands, spatial adjacencies relatin
257 t mammary gland and the pro-(BAX:Bcl(2)) and anti-[PKC alpha*(Bcl(2)/BAX)] apoptotic ratios were eval
258 '-epi-46, and 61) and several low-micromolar anti- Plasmodium falciparum lead compounds (i.e., 46, 2,
260 r in vivo anti- Pp IgG antibody nor in vitro anti- Pp T-cell response and resultant production of RAN
261 llate (EGCG), and matrix pH (2-7) on the net anti-/pro-oxidant activity of EGCG in flaxseed oil-in-wa
262 ing that quinoxaline antibiotics could exert anti- proliferative effects by inhibition of chromosomal
263 mutant ALG-1 and found that the mutant ALG-1(anti) protein fails to interact with numerous miRISC cof
265 he different stereochemical courses (syn and anti) result from different structural strategies for de
266 ) are compared with a commercially available anti- Salmonella antibody and the antimicrobial peptide
267 t)/anti-OH, SERO(B) at 32548 cm-1 to Gpy(up)/anti, SERO(C) at 32545 cm-1 to Gph(out)/anti, SERO(D) at
268 (up)/anti, SERO(C) at 32545 cm-1 to Gph(out)/anti, SERO(D) at 32560 cm-1 to Anti(py)/anti, SERO(E) at
269 out)/anti, SERO(D) at 32560 cm-1 to Anti(py)/anti, SERO(E) at 32537 cm-1 to Anti(up)/anti, SERO(F) at
270 (py)/anti, SERO(E) at 32537 cm-1 to Anti(up)/anti, SERO(F) at 32353 cm-1 to Gpy(out)/syn, SERO(G) at
271 ection, survival, yearly posttransplantation anti- serology, development of acute toxoplasmosis, and
272 ed on pretransplantation donor and recipient anti- serology, immunosuppression, allograft rejection,
274 5.2 (111.1) kJ/mol for the conversion of the anti (syn) to the syn (anti) isomer at 66.2 degrees C.
275 6.0 (112.1) kJ/mol for the conversion of the anti (syn) to the syn (anti) isomer at 71.0 degrees C.
276 rase interactions that influence templating (anti-/syn-equilibrium) of 8-oxoG while modulating fideli
279 n mast cells was suppressed by anti-IL-1 and anti- thymic stromal lymphopoietin (TSLP) and was enhanc
280 tive and specific screening serologic tests (anti- tissue transglutaminase antibodies IgA [anti-TTG]
281 r tests (IgA anti-dpgli, IgG anti-dpgli, IgA anti- tissue transglutaminase, and IgA anti-endomysium)
286 " cytokine in cancer, changing its role from anti- to pro-tumorigenic in a context-dependent manner.
296 ncreases 15-syn-retinal at the expense of 15-anti, which is the predominant isomer in the wild type,
297 in polymorph A away from each other (termed anti), while in polymorph B one methoxy group is oriente
298 he dimeric quadruplex contains two stacked G(anti) x G(anti) x G(anti) x G(syn) tetrads, one of which
299 quadruplex contains two stacked G(anti) x G(anti) x G(anti) x G(syn) tetrads, one of which forms a n
300 x contains two stacked G(anti) x G(anti) x G(anti) x G(syn) tetrads, one of which forms a newly ident
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。